Brazil's first oncology biotech launches

(New York, June 14)--Recepta, Brazil's first oncology biotechnology company was launched today by PR&D, a Brazilian venture capital company, and the international non-profit Ludwig Institute for Cancer Research (LICR). The company will explore the therapeutic potential of three antibodies discovered and characterized by LICR.

One of the antibodies in Receptas portfolio is expected to enter clinical trials this year. Internal review board permission has been granted by So Paulos Oswaldo Cruz German Hospital (HAOC), one of the centers of clinical excellence in Brazil, to conduct a clinical trial assessing the antibodys efficacy for patients with resected ovarian cancer. This will be the first phase II oncology clinical trial sponsored by a Brazilian company. Recepta will conduct preclinical work with investigators at the So Paulo Branch of LICR, which is based at HAOC.

According to the director of Recepta, Dr. Jos Fernando Perez, the company has benefited greatly from the international collaborations and support provided by LICR. Its important to appreciate that the Ludwig Institute is more than simply a share-holder in Recepta. This is a partnership that involves Ludwig Institute investigators from around the world contributing their knowledge and expertise to assist Receptas development efforts. Dr. Perez, who is the former director of FAPESP (State of Sao Paulo funding body), says that the partnership between LICR and PR&D evolved from an institutional partnership formed by LICR and FAPESP in the 1990s. That partnership created the internationally acclaimed ONSA (Organization for Nucleotide Sequencing and Analysis) and Human Cancer Genome Project (HCGP), state- and nation-wide sequencing programs, respectively, that brought Brazilian genomics to the worlds attention.

LICR's senior scientific officer, Dr. Andrew Simpson, who was a key player in ONSA and HCGP, says that the development of Recepta re-emphasizes the Institutes belief i

Contact: Sarah L. White
Ludwig Institute for Cancer Research

Page: 1 2

Related biology news :

1. Report shows deforestation threatens Brazils Pantanal
2. Selective logging causes widespread destruction of Brazils Amazon rainforest, study finds
3. Saudi Arabias KAUST names WHOI first research partner
4. Which came first, the moth or the cactus?
5. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
6. Seawater intrusion is the first cause of contamination of coastal aquifers
7. Camera-shy deer caught for first time
8. CTRC enrolls first patients in novel phase II study for sarcoma -- living virus destroys cancer cell
9. New joint replacement material developed at MGH put to first clinical use
10. Liverpool amongst first in UK to install unique DNA sequencing technology
11. A first-principles model of early evolution

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: